Ownership history in Walleye Capital LLC Β· 9 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in CORE LABORATORIES INC (CLB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Walleye Capital LLC underperformed the S&P 500 by β31.4% annually on this CLB position. Timing score: 17% (1/6 decisions correct). Average cost basis: $14.79. Maximum drawdown during holding period: β37.7%.
β Significantly underperformed the S&P 500 by 31.4% ann.
6 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
1 of 6 add/trim decisions correct
Best entry: $11.50 (2025 Q2) Β· Worst: $18.45 (2024 Q3)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
6 adds Β· 3 trims. Bought during 1 of 1 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size